| Rebekah Cynthia Ervin, PHARMD | |
|
1919 Fulton Ave, Sacramento, CA 95825-1905 | |
| (916) 483-5141 | |
| Not Available |
| Full Name | Rebekah Cynthia Ervin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1919 Fulton Ave, Sacramento, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093082273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 55209 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebekah Cynthia Ervin, PHARMD 1021 Hanover Ct, El Dorado Hills, CA 95762-4004 Ph: (916) 769-1488 | Rebekah Cynthia Ervin, PHARMD 1919 Fulton Ave, Sacramento, CA 95825-1905 Ph: (916) 483-5141 |
News Archive
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, presented additional preclinical data at the American Association of Cancer Research (AACR) Advances in Brain Cancer Research Conference on the potential for its lead product candidate VAL-083 (dianhydrogalactitol) to treat patients with temozolomide-resistant glioblastoma multiforme (GBM).
Clinical trials used by the Food and Drug Administration (FDA) to approve new drugs between 2005 and 2012 vary widely in their characteristics, according to a study in the January 22/29 issue of JAMA.
The New York Times reports: "The nation's drive toward computerized medical records is getting a push from big hospitals, which hope not only to improve patient care but to gain an edge on competitors. And an effort to be announced on Monday by a big New York regional hospital group may be the most ambitious effort of this type yet — a sizable investment intended as a linchpin in the group's $400 million commitment to digitize patient records throughout its system, including 13 hospitals."
Prostate cancer is the second leading cause of death among American men. It is estimated that one in six males will develop the disease during his lifetime. However, promising new treatment options have been developed to help combat this threatening disease.
The U.S. Food & Drug Administration granted accelerated approval to the drug enfortumab vedotin (EV) to treat adult patients with advanced urothelial or bladder cancer.
› Verified 4 days ago
Dr. Gina Maria Warren, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Broadway, Coumadin Clinic, Sacramento, CA 95820 Phone: 916-335-8818 | |
Dr. John Sung, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 Capitol Ave, Sacramento, CA 95816 Phone: 916-887-0350 | |
Mr. Gerald Lee Freitas I, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8364 Rovana Cir, Sacramento, CA 95828 Phone: 916-379-1657 Fax: 916-379-1691 | |
Michele Ang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3521 Del Paso Rd, Sacramento, CA 95835 Phone: 951-310-0758 | |
Colette Newman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4650 Natomas Blvd, Sacramento, CA 95835 Phone: 916-419-6644 Fax: 916-419-4764 | |
Dr. Anh Minh Phan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6051 Florin Rd, Sacramento, CA 95823 Phone: 916-427-9731 | |
Dr. Joyce He, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8241 E Stockton Blvd, Pharmacy Administration, Sacramento, CA 95828 Phone: 916-525-6900 |